Drug-induced cutaneous lupus erythematosus after immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a case series

2017 ◽  
Vol 22 (3) ◽  
pp. 213-218 ◽  
Author(s):  
Max E. Adrichem ◽  
Markus V. Starink ◽  
Ester M. M. van Leeuwen ◽  
Christine Kramer ◽  
Ivo N. van Schaik ◽  
...  
2018 ◽  
Vol 105 (2) ◽  
pp. 298-306
Author(s):  
Agata Kozłowska ◽  
Zdzisław Woźniak ◽  
Joanna Maj ◽  
Rafał Białynicki-Birula

2019 ◽  
Vol 12 (11) ◽  
pp. e230558 ◽  
Author(s):  
Jesse Hirner

A 52-year-old man was referred to our dermatology clinic for a diagnosis of melanoma. At the time, his melanoma was excised he developed an annular, polycyclic, scaling eruption consistent with subacute cutaneous lupus erythematosus (SCLE). Skin biopsy and laboratory evaluation confirmed this diagnosis. The patient had been using pantoprazole for gastro-oesophageal reflux disease for the last 3 years. The patient’s melanoma was treated surgically, and his SCLE was treated with topical steroids and hydroxychloroquine. His SCLE cleared rapidly, his steroids and hydroxychloroquine were stopped and he remains free of SCLE off of treatment. The parallel course of the patient’s SCLE and melanoma prompted consideration of SCLE as paraneoplastic to melanoma in this case. The clinical picture was complicated by the patient’s use of a proton pump inhibitor, which are common causes of drug-induced SCLE. To our knowledge, this is the first reported case of possible paraneoplastic SCLE associated with melanoma.


Sign in / Sign up

Export Citation Format

Share Document